Evidence map›Paper›PMID 35771030›Full record

ArticleJournal of diabetes science and technology2024

Insulin Requirements for Basal and Auto-Correction Insulin Delivery in Advanced Hybrid Closed-Loop System: 4193 Days' Real-World Data of Children in Two Different Age Groups.

Kağan Ege Karakuş, Gül Yeşiltepe Mutlu, Tuğba Gökçe, Elif Eviz, Ecem Can, Serra Muradoğlu, Şükrü Hatun

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024 · on this map
    Article
  7. Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kağan Ege KarakuşKoc University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-8552-5206
Gül Yeşiltepe MutluKoc University School of Medicine, Istanbul, Turkey.ORCID 0000-0003-3919-7763
Tuğba GökçeDivision of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey.
Elif EvizDivision of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey.ORCID 0000-0002-8889-6811
Ecem CanDivision of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey.
Serra MuradoğluDivision of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey.
Şükrü HatunKoc University School of Medicine, Istanbul, Turkey.
Koç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe insulin requirements of people with type 1 diabetes (T1D) can vary throughout the day due to factors such as biorhythm, exercise, and food intake. The MiniMed 780G system delivers micro boluses to adjust basal insulin and delivers auto-correction boluses to meet insulin needs when micro bolus increases are insufficient. Through analysis of MiniMed 780G data, this study investigates the variations in insulin requirements throughout the day.

methods4193 days' pump and continuous glucose monitoring (CGM) data of 34 children using MiniMed 780G were collected from Medtronic CareLink. Micro and auto-correction boluses were analyzed on an hourly basis for two age groups: below nine years old and above nine years old. Glycemic metrics were analyzed based on International CGM consensus.

resultsThe mean age was 12.3 years and mean duration of diabetes was 6.1 years. The mean time in range (TIR) and glucose management indicator (GMI) were 80.5% and 6.6%, respectively. The micro bolus (basal) ratio between 05.00 and 07.00 was significantly higher than the ratio between 10.00 and 03.00 (

conclusionThe basal insulin need follows a diurnal pattern with two significantly different periods-high between 00.00 and 10.00 and low between 10.00 and 00.00. The auto-correction rates are low between 05.00 and 10.00 and show an increasing pattern peaking between 21.00 and 00.00. These findings are compatible with the dawn and reverse dawn phenomena.

Indexed as

Diabetes Mellitus, Type 1InsulinBlood GlucoseBlood Glucose Self-MonitoringChildHumansInsulin, Regular, HumanBlood GlucoseInsulinInsulin, Regular, Humanadvanced closed-loop systemsbasal insulinphenomenontype 1 diabetes

Identifiers

PMID35771030
PMCPMC10973851
OpenAlexW4283717380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.